We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
- Authors
Kinslow, Connor J; DeStephano, David M; Neugut, Alfred I; Taparra, Kekoa; Horowitz, David P; Yu, James B; Cheng, Simon K
- Abstract
The COVID-19 pandemic caused widespread disruptions in cancer care. We hypothesized that the greatest disruptions in diagnosis occurred in screen-detected cancers. We identified patients (≥18 years of age) with newly diagnosed cancer from 2019 to 2020 in the US National Cancer Database and calculated the change in proportion of early-stage to late-stage cancers using a weighted linear regression. Disruptions in early-stage diagnosis were greater than in late-stage diagnosis (17% vs 12.5%). Melanoma demonstrated the greatest relative decrease in early-stage vs late-stage diagnosis (22.9% vs 9.2%), whereas the decrease was similar for pancreatic cancer. Compared with breast cancer, cervical, melanoma, prostate, colorectal, and lung cancers showed the greatest disruptions in early-stage diagnosis. Uninsured patients experienced greater disruptions than privately insured patients. Disruptions in cancer diagnosis in 2020 had a larger impact on early-stage disease, particularly screen-detected cancers. Our study supports emerging evidence that primary care visits may play a critical role in early melanoma detection.
- Subjects
COVID-19 pandemic; CANCER diagnosis
- Publication
JNCI Cancer Spectrum, 2024, Vol 8, Issue 3, p1
- ISSN
2515-5091
- Publication type
Article
- DOI
10.1093/jncics/pkae022